Total Payments
$6,290
2024 Payments
$777.00
Companies
26
Transactions
405
Medicare Patients
912
Medicare Billing
$179,873
Payment Breakdown by Category
Food & Beverage$6,078 (96.6%)
Consulting$150.00 (2.4%)
Education$61.15 (1.0%)
Other$0.00 (0.0%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $6,078 | 401 | 96.6% |
| Consulting Fee | $150.00 | 1 | 2.4% |
| Education | $61.15 | 3 | 1.0% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Otsuka America Pharmaceutical, Inc. | $1,138 | 80 | $0 (2024) |
| Lundbeck LLC | $702.53 | 46 | $0 (2023) |
| ABBVIE INC. | $641.91 | 50 | $0 (2024) |
| ITI, Inc. | $613.86 | 31 | $0 (2023) |
| Neurocrine Biosciences, Inc. | $494.78 | 19 | $0 (2024) |
| Shire North American Group Inc | $377.00 | 27 | $0 (2019) |
| Takeda Pharmaceuticals U.S.A., Inc. | $362.06 | 25 | $0 (2022) |
| Alkermes, Inc. | $317.95 | 11 | $0 (2024) |
| Allergan, Inc. | $239.29 | 26 | $0 (2020) |
| Sunovion Pharmaceuticals Inc. | $195.98 | 13 | $0 (2022) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $777.00 | 39 | Neurocrine Biosciences, Inc. ($254.91) |
| 2023 | $1,139 | 66 | ITI, Inc. ($296.80) |
| 2022 | $900.53 | 52 | ITI, Inc. ($317.06) |
| 2021 | $616.62 | 41 | AbbVie Inc. ($211.39) |
| 2020 | $273.53 | 14 | Lundbeck LLC ($97.98) |
| 2019 | $912.79 | 62 | Otsuka America Pharmaceutical, Inc. ($458.52) |
| 2018 | $736.06 | 64 | Shire North American Group Inc ($194.17) |
| 2017 | $933.68 | 67 | Otsuka America Pharmaceutical, Inc. ($246.69) |
All Payment Transactions
405 individual payment records from CMS Open Payments — Page 1 of 17
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/20/2024 | ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | CAPLYTA (Drug) | Food and Beverage | In-kind items and services | $11.69 | General |
| Category: PSYCHIATRY | ||||||
| 12/14/2024 | Vanda Pharmaceuticals Inc. | HETLIOZ (Drug), FANAPT | Food and Beverage | In-kind items and services | $14.95 | General |
| Category: NON-24-HOUR SLEEP-WAKE DISORDER | ||||||
| 12/07/2024 | Otsuka America Pharmaceutical, Inc. | REXULTI (Drug) | Food and Beverage | In-kind items and services | $19.47 | General |
| Category: PSYCHIATRY | ||||||
| 11/22/2024 | Alkermes, Inc. | ARISTADA (Drug), ARISTADA, ARISTADA | Food and Beverage | In-kind items and services | $29.06 | General |
| Category: CNS | ||||||
| 11/15/2024 | ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | CAPLYTA (Drug) | Food and Beverage | In-kind items and services | $5.74 | General |
| Category: PSYCHIATRY | ||||||
| 11/03/2024 | ABBVIE INC. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $17.19 | General |
| Category: NEUROSCIENCE | ||||||
| 09/13/2024 | ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | CAPLYTA (Drug) | Food and Beverage | In-kind items and services | $8.81 | General |
| Category: PSYCHIATRY | ||||||
| 08/24/2024 | Neurocrine Biosciences, Inc. | INGREZZA (Drug) | Food and Beverage | In-kind items and services | $24.22 | General |
| Category: Neuropsychiatry | ||||||
| 08/16/2024 | ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | CAPLYTA (Drug) | Food and Beverage | In-kind items and services | $4.69 | General |
| Category: PSYCHIATRY | ||||||
| 07/19/2024 | ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | CAPLYTA (Drug) | Food and Beverage | In-kind items and services | $3.48 | General |
| Category: PSYCHIATRY | ||||||
| 07/13/2024 | ABBVIE INC. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $33.58 | General |
| Category: NEUROSCIENCE | ||||||
| 06/15/2024 | Otsuka America Pharmaceutical, Inc. | REXULTI (Drug) | Food and Beverage | In-kind items and services | $16.82 | General |
| Category: PSYCHIATRY | ||||||
| 06/07/2024 | Axsome Therapeutics, Inc. | Auvelity (Drug) | Food and Beverage | In-kind items and services | $16.01 | General |
| Category: Psychology/Psychiatric | ||||||
| 05/31/2024 | Neurocrine Biosciences, Inc. | INGREZZA (Drug) | Food and Beverage | In-kind items and services | $32.29 | General |
| Category: Neuropsychiatry | ||||||
| 05/31/2024 | ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | CAPLYTA (Drug) | Food and Beverage | In-kind items and services | $11.44 | General |
| Category: PSYCHIATRY | ||||||
| 05/10/2024 | ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | CAPLYTA (Drug) | Food and Beverage | In-kind items and services | $8.09 | General |
| Category: PSYCHIATRY | ||||||
| 04/26/2024 | ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | CAPLYTA (Drug) | Food and Beverage | In-kind items and services | $8.77 | General |
| Category: PSYCHIATRY | ||||||
| 04/19/2024 | ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | CAPLYTA (Drug) | Food and Beverage | In-kind items and services | $23.92 | General |
| Category: PSYCHIATRY | ||||||
| 04/09/2024 | Otsuka America Pharmaceutical, Inc. | REXULTI (Drug) | Food and Beverage | In-kind items and services | $19.64 | General |
| Category: PSYCHIATRY | ||||||
| 03/26/2024 | Neurocrine Biosciences, Inc. | INGREZZA (Drug) | Food and Beverage | In-kind items and services | $26.01 | General |
| Category: Neuropsychiatry | ||||||
| 03/25/2024 | Janssen Pharmaceuticals, Inc | SPRAVATO (Drug) | Food and Beverage | In-kind items and services | $21.61 | General |
| Category: Neuroscience | ||||||
| 03/13/2024 | ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | CAPLYTA (Drug) | Food and Beverage | In-kind items and services | $22.90 | General |
| Category: PSYCHIATRY | ||||||
| 03/12/2024 | ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | CAPLYTA (Drug) | Food and Beverage | In-kind items and services | $5.06 | General |
| Category: PSYCHIATRY | ||||||
| 03/06/2024 | Neurocrine Biosciences, Inc. | INGREZZA (Drug) | Food and Beverage | In-kind items and services | $21.67 | General |
| Category: Neuropsychiatry | ||||||
| 03/06/2024 | Noven Therapeutics, LLC | Xelstrym (Drug), Secuado | Food and Beverage | In-kind items and services | $14.94 | General |
| Category: ADHD | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 7 | 490 | 1,004 | $216,565 | $93,663 |
| 2022 | 2 | 91 | 266 | $52,670 | $24,299 |
| 2021 | 3 | 111 | 376 | $69,350 | $32,328 |
| 2020 | 5 | 220 | 449 | $63,652 | $29,583 |
Total Patients
912
Total Services
2,095
Medicare Billing
$179,873
Procedure Codes
19
All Medicare Procedures & Services
19 procedure records from CMS Medicare Utilization
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 78 | 285 | $52,790 | $24,808 | 47.0% |
| 90792 | Psychiatric diagnostic evaluation with medical services | Office | 2023 | 155 | 156 | $61,785 | $22,545 | 36.5% |
| 99309 | Subsequent nursing facility care with moderate level of medical decision making, per day, if using time, at least 30 minutes | Office | 2023 | 81 | 208 | $29,120 | $17,231 | 59.2% |
| 90792 | Psychiatric diagnostic evaluation with medical services | Facility | 2023 | 65 | 65 | $26,000 | $8,572 | 33.0% |
| 99309 | Subsequent nursing facility care with moderate level of medical decision making, per day, if using time, at least 30 minutes | Facility | 2023 | 44 | 85 | $11,900 | $7,041 | 59.2% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 17 | 102 | $12,750 | $6,497 | 51.0% |
| 99349 | Residence visit for established patient with moderate level of medical decision making, per day, if using time, at least 40 minutes | Office | 2023 | 22 | 33 | $9,900 | $3,269 | 33.0% |
| 90833 | Psychotherapy with evaluation and management visit, 30 minutes | Office | 2023 | 11 | 49 | $9,800 | $2,487 | 25.4% |
| 99308 | Subsequent nursing facility care with straightforward level of medical decision making, per day, if using time, at least 15 minutes | Office | 2023 | 17 | 21 | $2,520 | $1,213 | 48.1% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 75 | 250 | $46,510 | $21,796 | 46.9% |
| 90792 | Psychiatric diagnostic evaluation with medical services | Office | 2022 | 16 | 16 | $6,160 | $2,503 | 40.6% |
| 99214 | Established patient outpatient visit, total time 30-39 minutes | Office | 2021 | 82 | 287 | $53,095 | $24,905 | 46.9% |
| 99213 | Established patient outpatient visit, total time 20-29 minutes | Office | 2021 | 14 | 74 | $10,750 | $5,219 | 48.6% |
| 90792 | Psychiatric diagnostic evaluation with medical services | Office | 2021 | 15 | 15 | $5,505 | $2,203 | 40.0% |
| 99214 | Established patient office or other outpatient, visit typically 25 minutes | Office | 2020 | 103 | 236 | $37,035 | $15,956 | 43.1% |
| 99213 | Established patient office or other outpatient visit, typically 15 minutes | Office | 2020 | 27 | 85 | $9,475 | $4,536 | 47.9% |
| 99442 | Physician telephone patient service, 11-20 minutes of medical discussion | Office | 2020 | 53 | 76 | $6,849 | $3,954 | 57.7% |
| 90792 | Psychiatric diagnostic evaluation with medical services | Office | 2020 | 22 | 22 | $6,535 | $2,691 | 41.2% |
| 99443 | Physician telephone patient service, 21-30 minutes of medical discussion | Office | 2020 | 15 | 30 | $3,758 | $2,446 | 65.1% |
About Dr. Kenneth Fore, MD
Dr. Kenneth Fore, MD is a Psychiatry healthcare provider based in Portsmouth, Virginia. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 06/06/2007. The National Provider Identifier (NPI) number assigned to this provider is 1407059637.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Kenneth Fore, MD has received a total of $6,290 in payments from pharmaceutical and medical device companies, with $777.00 received in 2024. These payments were reported across 405 transactions from 26 companies. The most common payment nature is "Food and Beverage" ($6,078).
As a Medicare-enrolled provider, Fore has provided services to 912 Medicare beneficiaries, totaling 2,095 services with total Medicare billing of $179,873. Data is available for 4 years (2020–2023), covering 19 distinct procedure/service records.
Ad
Practice Information
- Specialty Psychiatry
- Location Portsmouth, VA
- Active Since 06/06/2007
- Last Updated 10/30/2025
- Taxonomy Code 2084P0800X
- Entity Type Individual
- NPI Number 1407059637
Products in Payments
- REXULTI (Drug) $1,340
- VRAYLAR (Drug) $881.20
- CAPLYTA (Drug) $801.35
- INGREZZA (Drug) $494.78
- BRINTELLIX (Drug) $406.22
- VYVANSE (Drug) $231.26
- MYDAYIS (Drug) $204.58
- Trintellix (Drug) $200.62
- LATUDA (Drug) $195.98
- TRINTELLIX (Drug) $191.09
- Auvelity (Drug) $139.11
- Evekeo (Drug) $127.84
- QELBREE (Drug) $126.95
- QUVIVIQ (Drug) $103.61
- ARISTADA (Drug) $100.70
- ABILIFY MAINTENA (Drug) $80.35
- LYBALVI (Drug) $67.25
- AUSTEDO (Drug) $49.58
- Qelbree (Drug) $46.84
- Jornay PM 20mg capsules (Bottle of 100) (Drug) $41.02
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Psychiatry Doctors in Portsmouth
Sallyanne Pyle, D.o, D.O
Psychiatry — Payments: $32,029
Psychiatry $32,029
Dr. Joshua Cole, Md, MD
Psychiatry — Payments: $5,542
Psychiatry $5,542
Dr. George Nowak, Md, MD
Psychiatry — Payments: $4,736
Psychiatry $4,736
Dr. Federico Vizcaino, Md, MD
Psychiatry — Payments: $3,871
Psychiatry $3,871
Dr. Malcolm Beaudett, M.d, M.D
Psychiatry — Payments: $3,770
Psychiatry $3,770
Andrew Morris, Md, MD
Psychiatry — Payments: $3,190
Psychiatry $3,190